Trial Profile
Adverse Event Data Collection From External Registries on Nonacog Beta Pegol
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 Jan 2022
Price :
$35
*
At a glance
- Drugs Nonacog beta pegol (Primary)
- Indications Haemophilia B
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 19 Dec 2019 Planned number of patients changed from 30 to 10.
- 07 Nov 2018 Status changed from not yet recruiting to recruiting.
- 08 Oct 2018 New trial record